Bill Ackman Says Valeant Pharmaceuticals Bet Is Mirror Image Of His Herbalife Short

November 10, 2015   |   November 2015 Bond Updates
Pershing Square's Bill Ackman said Valeant's tumble from above $250 a share to below $80 a share reminded him of Herbalife's surge in late 2013, which caused the stock to roughly double to about $80 a share.

View more at: http://www.forbes.com/sites/antoinegara/2015/11/09/bill-ackman-says-his-valeant-pharmaceuticals-bet-is-at-an-herbalife-moment/
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/